SCHEMBL7315293

SCHEMBL7315293

Cc1cccc2c1C(OC(C)[C@H](N)C(=O)O)(c1ccccc1)c1ccccc1-2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 6/20 0.40
CYP1A2 P05177 4/20 0.35
CYP2C19 P33261 4/20 0.35
CYP2C9 P11712 3/20 0.35
NPSR1 Q6W5P4 3/20 0.35
CYP3A4 P08684 2/20 0.35
HTT P42858 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ATM Q13315 1/20 0.34
MYC P01106 1/20 0.34
SLC1A3 P43003 3/20 0.33
SLC1A2 P43004 3/20 0.33
SLC1A1 P43005 3/20 0.33
PDK2 Q15119 2/20 0.33
HIF1A Q16665 1/20 0.33
MEN1 O00255 1/20 0.32
CYP2D6 P10635 1/20 0.32
KMT2A Q03164 1/20 0.32
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7315297 1.00 KIF11 (0.40) KIF11CYP1A2CYP2C19CYP2C9NPSR1
SCHEMBL7323867 0.89 KIF11 (0.44) KIF11CYP1A2CYP2C19CYP2C9ATM
SCHEMBL7317362 0.89 KIF11 (0.44) KIF11CYP1A2CYP2C19CYP2C9ATM
SCHEMBL7317367 0.89 KIF11 (0.44) KIF11CYP1A2CYP2C19CYP2C9ATM
SCHEMBL7320886 0.88 PDK2 (0.39) KIF11CYP1A2CYP2C19CYP2C9NPSR1
SCHEMBL7320880 0.88 PDK2 (0.39) KIF11CYP1A2CYP2C19CYP2C9NPSR1
SCHEMBL7325812 0.86 KIF11 (0.38) KIF11CYP1A2CYP2C19CYP2C9ATM
SCHEMBL7325808 0.86 KIF11 (0.38) KIF11CYP1A2CYP2C19CYP2C9ATM
SCHEMBL7312848 0.85 KIF11 (0.41) KIF11CYP1A2CYP2C19CYP2C9NPSR1
SCHEMBL7320455 0.85 KIF11 (0.41) KIF11CYP1A2CYP2C19CYP2C9NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6162824-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS ALLELIX NEUROSCIENCE INC. 2000-12-19 US disclosed